Drug extrusion in Corynebacterium glutamicum

Microb Drug Resist. 1997 Winter;3(4):345-50. doi: 10.1089/mdr.1997.3.345.

Abstract

We selected a mutant of Corynebacterium glutamicum, EBR, which can grow in a medium containing cytotoxic ethidium bromide (EtBr) at a high concentration of 100 microM. The resistance to EtBr in the mutant was reversed by 2 microM reserpine, a potent inhibitor of mammalian p-glycoprotein and bacterial multidrug resistance (MDR) transporter, whereas reserpine alone had a minimal effect on cell growth. The mutant showed a much higher efflux rate of EtBr than wild-type cells, and the efflux was completely inhibited by 2 microM reserpine. In addition to reserpine, structurally unrelated chemicals such as quinidine, trifluorperazine, tetraphenylarsonium chloride, chlorpromazine and quinine inhibit the EtBr efflux, revealing that the putative efflux system(s) can recognize a variety of chemicals. The efflux activity was correlated with the membrane potential but not the intracellular ATP contents. We, therefore, concluded that the EtBr resistance may be involved by proton-motive-force driven multidrug efflux system(s).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Anti-Bacterial Agents / metabolism*
  • Anti-Bacterial Agents / pharmacology
  • Corynebacterium / genetics
  • Corynebacterium / metabolism*
  • Drug Resistance, Microbial / genetics
  • Drug Resistance, Multiple
  • Ethidium / metabolism*
  • Ethidium / pharmacology
  • Genes, MDR
  • Membrane Potentials / drug effects
  • Microbial Sensitivity Tests
  • Mutation
  • Reserpine / pharmacology

Substances

  • Anti-Bacterial Agents
  • Reserpine
  • Adenosine Triphosphate
  • Ethidium